Corporate News 10-Apr-17
Ajanta Pharma intimates of successful inspection of its facility at Dahej
By USFDA
Ajanta Pharma announced that its formulations facility at Dahej was inspected by USFDA from 03 April to 07 April 2017. At the end of the inspection, no Form 483 was issued to the Company.
Previous News
Ajanta Pharma fixes record date for bonus issue
( Market Beat - Reports 13-Jun-22 13:07 )
Ajanta Pharma slips after US FDA issues form 483 to Dahej facility
( Hot Pursuit - 12-Sep-22 11:59 )
Ajanta Pharma to conduct board meeting
( Corporate News - 22-Jan-22 12:21 )
Ajanta Pharma consolidated net profit declines 20.08% in the September 2022 quarter
( Results - Announcements 03-Nov-22 16:33 )
Ajanta Pharma AGM scheduled
( Corporate News - 15-Jun-24 10:25 )
Ajanta Pharma consolidated net profit rises 8.36% in the June 2019 quarter
( Results - Announcements 02-Aug-19 08:23 )
Ajanta Pharma consolidated net profit declines 54.63% in the December 2018 quarter
( Results - Announcements 31-Jan-19 08:57 )
Ajanta Pharma
( Results - Analysis 03-Nov-22 20:33 )
Ajanta Pharma allots 7500 equity shares
( Corporate News - 14-Sep-18 12:43 )
Volumes soar at Trident Ltd counter
( Hot Pursuit - 28-Jul-21 11:00 )
Ajanta Pharma standalone net profit rises 96.56% in the June 2018 quarter
( Results - Announcements 31-Jul-18 16:32 )
Other Stories
Vardhan Capital & Finance schedules AGM
06-Jul-24 17:34
Automotive Axles schedules AGM
06-Jul-24 17:34
Maruti Infrastructure to conduct AGM
06-Jul-24 17:34
Torrent Power schedules AGM
06-Jul-24 17:34
Raghav Productivity Enhancers to hold AGM
06-Jul-24 17:34
Berger Paints India schedules AGM
06-Jul-24 17:33
Walpar Nutritions to conduct AGM
06-Jul-24 17:33
Weizmann AGM scheduled
06-Jul-24 17:33
Gretex Industries schedules AGM
06-Jul-24 17:33
Karma Energy schedules AGM
06-Jul-24 17:33
Back
Top
